Paper38422397
Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability.
Sarin D and 4 others. Mol Pharm, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability. Papers, record 38422397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38422397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability.
- PubMed
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Biosimilar Pharmaceuticals | Major topic |
| Excipients |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 FD007758 | FDA HHS | United States | U01FD007758 | PubMed and NIH |
Source NIH RePORTER
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30339478 | Charge variant native mass spectrometry benefits mass precision and dynamic range of monoclonal antibody intact mass analysis. | MAbs | 2018 | https://conductscience.org/library/papers/30339478 | PubMed |
| 2 | 34890632 | Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy. | J Pharm Sci | 2022 | https://conductscience.org/library/papers/34890632 | PubMed |
| 3 | 31584804 | Automated High-Throughput Capillary Circular Dichroism and Intrinsic Fluorescence Spectroscopy for Rapid Determination of Protein Structure. | Anal Chem | 2019 | https://conductscience.org/library/papers/31584804 | PubMed |
| 4 | 29913140 | Enhanced Precision of Circular Dichroism Spectral Measurements Permits Detection of Subtle Higher Order Structural Changes in Therapeutic Proteins. | J Pharm Sci | 2018 | https://conductscience.org/library/papers/29913140 | PubMed |
| 5 | 31975160 | Assessment of Structural and Functional Comparability of Biosimilar Products: Trastuzumab as a Case Study. | BioDrugs | 2020 | https://conductscience.org/library/papers/31975160 | PubMed |
| 6 | 30794092 | Physicochemical and functional assessments demonstrating analytical similarity between rituximab biosimilar HLX01 and the MabThera®. | MAbs | 2019 | https://conductscience.org/library/papers/30794092 | PubMed |
| 7 | 29411222 | Physicochemical Characterization, Glycosylation Pattern and Biosimilarity Assessment of the Fusion Protein Etanercept. | Protein J | 2018 | https://conductscience.org/library/papers/29411222 | PubMed |
| 8 | 36877356 | Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry. | Arch Pharm Res | 2023 | https://conductscience.org/library/papers/36877356 | PubMed |
| 9 | 33718433 | Characterizing Hydropathy of Amino Acid Side Chain in a Protein Environment by Investigating the Structural Changes of Water Molecules Network. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/33718433 | PubMed |
| 10 | 27347568 | Circular dichroism spectroscopy of membrane proteins. | Chem Soc Rev | 2016 | https://conductscience.org/library/papers/27347568 | PubMed |
| 11 | 31053815 | The influence of domestic manufacturing capabilities on biologic pricing in emerging economies. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/31053815 | PubMed |
| 12 | 25630820 | Nanoparticulate Impurities in Pharmaceutical-Grade Sugars and their Interference with Light Scattering-Based Analysis of Protein Formulations. | Pharm Res | 2015 | https://conductscience.org/library/papers/25630820 | PubMed |
| 13 | 33776419 | The Current Status of Gene Therapy for the Treatment of Cancer. | Biologics | 2021 | https://conductscience.org/library/papers/33776419 | PubMed |
| 14 | 30639740 | Probing the Tryptophan Environment in Therapeutic Proteins: Implications for Higher Order Structure on Tryptophan Oxidation. | J Pharm Sci | 2019 | https://conductscience.org/library/papers/30639740 | PubMed |
| 15 | 28439817 | Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community. | BioDrugs | 2017 | https://conductscience.org/library/papers/28439817 | PubMed |
| 16 | 18988034 | High-throughput protein concentration and buffer exchange: comparison of ultrafiltration and ammonium sulfate precipitation. | Methods Mol Biol | 2009 | https://conductscience.org/library/papers/18988034 | PubMed |
| 17 | 18429288 | Desalting, concentration, and buffer exchange by dialysis and ultrafiltration. | Curr Protoc Protein Sci | 2005 | https://conductscience.org/library/papers/18429288 | PubMed |
| 18 | 31071101 | Conformational characterization of a novel anti-HER2 candidate antibody. | PLoS One | 2019 | https://conductscience.org/library/papers/31071101 | PubMed |
| 19 | 30031090 | Buffer exchange path influences the stability and viscosity upon storage of a high concentration protein. | Eur J Pharm Biopharm | 2018 | https://conductscience.org/library/papers/30031090 | PubMed |
| 20 | 20647768 | Recovery and purification process development for monoclonal antibody production. | MAbs | 2010 | https://conductscience.org/library/papers/20647768 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930999 | An Economical, Scaled-Down, Suction-Based Tangential Flow Ultrafiltration System for Biological Process and Product Development Applications. | Membranes (Basel) | 2026 | https://conductscience.org/library/papers/42930999 | PubMed |
| 42864475 | Screening of Unexplored FDA-approved Inactive Ingredients as Stabilizers for Monoclonal Antibody Products. | Pharm Res | 2026 | https://conductscience.org/library/papers/42864475 | PubMed |
| 42844487 | Statistical Tools for Biosimilarity Assessment: A Perspective Based on WHO-recommended Approaches. | AAPS J | 2026 | https://conductscience.org/library/papers/42844487 | PubMed |
| 41709016 | Best Practices for Performing Analytical and Functional Biosimilarity Assessment of Recombinant Monoclonal Antibody Biosimilars. | AAPS J | 2026 | https://conductscience.org/library/papers/41709016 | PubMed |
| 41012519 | Formulation of Recombinant Therapeutic Proteins: Technological Innovation, Regulations, and Evolution Towards Buffer-Free Formulations. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012519 | PubMed |
| 40573303 | Innovative Formulation Strategies for Biosimilars: Trends Focused on Buffer-Free Systems, Safety, Regulatory Alignment, and Intellectual Property Challenges. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40573303 | PubMed |
| 40316853 | Removal of Excipients from Drug Product may Impact Antibody Characterization of Monoclonal Antibodies. | AAPS J | 2025 | https://conductscience.org/library/papers/40316853 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38422397
GET https://conductscience.org/api/papers/v1/38422397/references?page=2